Stella Diagnostics (Stella Diagnostics) EBIT per Share : $ (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics EBIT per Share?

Stella Diagnostics's EBIT per Share for the three months ended in Sep. 2023 was $-0.00. Stella Diagnostics does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Stella Diagnostics's EBIT per Share or its related term are showing as below:

SLDX's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -1.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Stella Diagnostics's EBIT for the three months ended in Sep. 2023 was $-0.78 Mil.

Stella Diagnostics EBIT per Share Historical Data

The historical data trend for Stella Diagnostics's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics EBIT per Share Chart

Stella Diagnostics Annual Data

Trend

EBIT per Share

Stella Diagnostics Quarterly Data
	Sep22	Sep23
EBIT per Share	-0.01	-

Stella Diagnostics EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Stella Diagnostics's EBIT per Share for the fiscal year that ended in . 20 is calculated as

	EBIT per Share		(A: . 20 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=		/	0
=	N/A

Stella Diagnostics's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.777	/	401.600
=	-0.00

Stella Diagnostics (OTCPK:SLDX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Stella Diagnostics EBIT per Share Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.